✦ LIBER ✦

Characterization of Reverse Transcriptase Activity and Susceptibility to Other Nucleosides of AZT-Resistant Variants of HIV-1 : Results from the Canadian AZT Multicentre Study

✍ Scribed by MARK A. WAINBERG; MICHEL TREMBLAY; RONALD ROOKE; NORMAND BLAIN; HUGO SOUDEYNS; MICHAEL A. PARNIAK; X-J YAO; X-G LI; MARY FANNING; JULIO S. G. MONTANER; MICHAEL O'SHAUGHNESSY; CHRISTOS TSOUKAS; JULIAN FALUTZ; GERVAIS DIONNE; BERNARD BELLEAU; JOHN RUEDY

Book ID: 119864125
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 504 KB
Volume: 616
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.1990.tb17855.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

94 Combination therapy with AZT prevents

94 Combination therapy with AZT prevents selection of HIV-1 variants that are highly resistant to the nonnucleoside reverse transcriptase inhibitor L-697, 661: E.A. Emini, S. Staszewski, C.L. Schneider, J.A. Waterbury, W.A. Schleif, R. Goehler, A. Deussen, S. Duerr, F.E. Massari, G.B. Calandra, B. Hoffstedt, and V.W. Byrnes; Merck Research Laboratories, West Point, PA, USA; Klinikum der Johann Wolfgang Goethe-Universitat, Frankfurt, Germany

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 92 KB